Sort by
Refine Your Search
-
Employer
-
Field
-
pharmacological treatment options that delay or halt the progression of OA. In this project, we aim to identify unique small-molecule-based disease-modifying drugs (DMOADs) that can provide a biomolecular basis for
-
million patients. Despite these pessimistic patient numbers, the massive global impact of OA on socio-economic systems and the quality of life for the individual patient, there are no pharmacological
Searches related to clinical pharmacology
Enter an email to receive alerts for clinical-pharmacology positions